{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T04:30:13Z","timestamp":1781325013417,"version":"3.54.1"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T00:00:00Z","timestamp":1515024000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Scientific Research Project Coordination Unit of Necmettin Erbakan University","award":["161518001"],"award-info":[{"award-number":["161518001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Child Adolesc Psychiatry"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1007\/s00787-017-1099-3","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T06:29:24Z","timestamp":1515047364000},"page":"977-984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive\u2013compulsive disorder"],"prefix":"10.1007","volume":"27","author":[{"given":"Rukiye","family":"\u00c7olak Sivri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayhan","family":"Bilgi\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130brahim","family":"K\u0131l\u0131n\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,4]]},"reference":[{"key":"1099_CR1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1753-2000-7-20","volume":"7","author":"R Bipeta","year":"2013","unstructured":"Bipeta R, Yerramilli SS, Pingali S, Karredla AR, Ali MO (2013) A crosssectional study of insight and family accommodation in pediatric obsessive-compulsive disorder. Child Adolesc Psychiatry Ment Health 7:20","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"1099_CR2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00787-012-0357-7","volume":"22","author":"PH Thomsen","year":"2013","unstructured":"Thomsen PH (2013) Obsessive\u2013compulsive disorders. Eur Child Adolesc Psychiatry 22:23\u201328","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"1099_CR3","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s11920-012-0272-0","volume":"14","author":"SM Gray","year":"2012","unstructured":"Gray SM, Bloch MH (2012) Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep 14:220\u2013228","journal-title":"Curr Psychiatry Rep"},{"key":"1099_CR4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11908-010-0082-7","volume":"12","author":"S Oliveira","year":"2010","unstructured":"Oliveira S, Pelajo C (2010) Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection (PANDAS): a controversial diagnosis. Curr Infect Dis Rep 12:103\u2013109","journal-title":"Curr Infect Dis Rep"},{"key":"1099_CR5","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.pnpbp.2007.12.026","volume":"32","author":"FF Rocha","year":"2008","unstructured":"Rocha FF, Correa H, Teixeira AL (2008) Obsessive-compulsive disorder and immunology: a review. Prog Neuropsychopharmacol Biol Psychiatry 32:1139\u20131146","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1099_CR6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaac.2013.11.013","volume":"53","author":"RCB Mitchell","year":"2014","unstructured":"Mitchell RCB, Goldstein BI (2014) Inflammation in children and adolescents with neuropsychiatric disorders: a systematic review. J Am Acad Child Adolesc Psychiatry 53:274\u2013296","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1099_CR7","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0006-3223(96)00495-7","volume":"42","author":"F Brambilla","year":"1997","unstructured":"Brambilla F, Perna G, Bellodi L, Arancio C, Bertani A, Perini G, Carraro C, Gava F (1997) Plasma interleukin-1\u03b2 and tumor necrosis factor concentrations in obsessive-compulsive disorders. Biol Psychiatry 42:976\u2013981","journal-title":"Biol Psychiatry"},{"key":"1099_CR8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1159\/000026500","volume":"37","author":"P Monteleone","year":"1998","unstructured":"Monteleone P, Catapano F, Fabrazzo M, Tortorella A, Maj M (1998) Decreased blood levels of tumor necrosis factor-alpha in patients with obsessive-compulsive disorder. Neuropsychobiology 37:182\u2013185","journal-title":"Neuropsychobiology"},{"key":"1099_CR9","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.psyneuen.2003.08.008","volume":"29","author":"D Denys","year":"2004","unstructured":"Denys D, Fluitman S, Kavelaars A, Heijnen C, Westenberg H (2004) Decreased TNF-\u03b1 and NK activity in obsessive-compulsive disorder. Psychoneuroendocrinology 29:945\u2013952","journal-title":"Psychoneuroendocrinology"},{"key":"1099_CR10","doi-asserted-by":"crossref","first-page":"65704","DOI":"10.1155\/2007\/65704","volume":"2007","author":"N Konuk","year":"2007","unstructured":"Konuk N, Tekin IO, Ozturk U, Atik L, Atasoy N, Bektas S, Erdogan A (2007) Plasma levels of tumor necrosis factor-alpha and interleukin-6 in obsessive compulsive disorder. Mediators Inflamm 2007:65704","journal-title":"Mediators Inflamm"},{"key":"1099_CR11","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","volume":"57","author":"JF Leckman","year":"2005","unstructured":"Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kr\u00f6nig H et al (2005) Increasedserum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette\u2019s syndrome. Biol Psychiatry 57:667\u2013673","journal-title":"Biol Psychiatry"},{"key":"1099_CR12","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-244X-12-29","volume":"12","author":"J Matz","year":"2012","unstructured":"Matz J, Krause DL, Dehning S, Riedel M, Gruber R, Schwarz MJ, M\u00fcller N (2012) Altered monocyte activation markers in Tourette\u2019s syndrome: a case-control study. BMC Psychiatry 12:29","journal-title":"BMC Psychiatry"},{"key":"1099_CR13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.pnpbp.2010.06.028","volume":"34","author":"NG Bos-Veneman","year":"2010","unstructured":"Bos-Veneman NG, Bijzet J, Limburg PC, Minderaa RB, Kallenberg CG, Hoekstra PJ (2010) Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder. Prog Neuropsychopharmacol Biol Psychiatry 34:1390\u20131395","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1099_CR14","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.pnpbp.2009.05.001","volume":"33","author":"V Gabbay","year":"2009","unstructured":"Gabbay V, Coffey BJ, Guttman LE, Gottlieb L, Katz Y, Babb JS, Hamamoto MM, Gonzalez CJ (2009) A cytokine study in children and adolescents with Tourette\u2019s disorder. Neuropsychopharmacol Biol Psychiatry 33:967\u2013971","journal-title":"Neuropsychopharmacol Biol Psychiatry"},{"key":"1099_CR15","first-page":"855","volume":"77","author":"\u015e \u015eim\u015fek","year":"2016","unstructured":"\u015eim\u015fek \u015e, Gen\u00e7o\u011flan S, Y\u00fcksel T, Kaplan \u0130, Alaca R (2016) Cortisol and brain-derived neurotrophic factor levels prior to treatment in children with obsessive-compulsive disorder. J ClinPsychiatry 77:855\u2013859","journal-title":"J ClinPsychiatry"},{"key":"1099_CR16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1176\/appi.ajp.157.5.683","volume":"157","author":"Z Kronfol","year":"2000","unstructured":"Kronfol Z, Remick DG (2000) Cytokines and the brain: implications for clinical psychiatry. Am Psychiatry 157:683\u2013694","journal-title":"Am Psychiatry"},{"key":"1099_CR17","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.comppsych.2011.12.007","volume":"53","author":"LF Fontenelle","year":"2012","unstructured":"Fontenelle LF, Barbosa IG, Luna JV, de Sousa LP, Abreu MN, Teixeira AL (2012) A cytokine study of adult patients with obsessive-compulsive disorder. Compr Psychiatry 53:797\u2013804","journal-title":"Compr Psychiatry"},{"key":"1099_CR18","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1601-5215.2011.00616.x","volume":"24","author":"S Liu","year":"2012","unstructured":"Liu S, Liu Y, Yin Y, Zhang X, Ma X (2012) A case-control study of interleukin-12 1188A\/C polymorphism in obsessive-compulsive disorder in Chinese population. Acta Neuropsychiatr 24:172\u2013175","journal-title":"Acta Neuropsychiatr"},{"key":"1099_CR19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000119136","volume":"30","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E (1994) Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations. Neuropsychobiology 30:57\u201360","journal-title":"Neuropsychobiology"},{"key":"1099_CR20","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/s10165-008-0099-z","volume":"18","author":"H Takatori","year":"2008","unstructured":"Takatori H, Kanno Y, Chen Z, O\u2019Shea JJ (2008) New complexities in helper T cell fate determination and the implications for autoimmune diseases. Mod Rheumatol 18:533\u2013541","journal-title":"Mod Rheumatol"},{"key":"1099_CR21","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","volume":"13","author":"H Kebir","year":"2007","unstructured":"Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M et al (2007) Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med 13:1173\u20131175","journal-title":"Nat Med"},{"key":"1099_CR22","doi-asserted-by":"crossref","first-page":"5607","DOI":"10.1007\/s11033-013-2662-8","volume":"40","author":"D Frydecka","year":"2013","unstructured":"Frydecka D, Misiak B, Beszlej JA, Karabon L, Pawlak-Adamska E, Tomkiewicz A, Jonkisz A, Kiejna A (2013) Genetic variants in transforming growth factor-beta gene (TGFB1) affect susceptibility to Schizophrenia. Mol Biol Rep 40:5607\u20135614","journal-title":"Mol Biol Rep"},{"key":"1099_CR23","first-page":"137","volume":"7","author":"MH Davami","year":"2016","unstructured":"Davami MH, Baharlou R, Ahmadi Vasmehjani A, Ghanizadeh A, Keshtkar M, Dezhkam I, Atashzar MR (2016) Elevated IL-17 and TGF-\u03b2 serum levels: a positive correlation between T-helper 17 cell-related pro-inflammatory responses with major depressive disorder. Basic Clin Neurosci 7:137\u2013142","journal-title":"Basic Clin Neurosci"},{"key":"1099_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jad.2014.12.033","volume":"174","author":"H Li","year":"2015","unstructured":"Li H, Hong W, Zhang C, Wu Z, Wang Z, Yuan C, Li Z, Huang J, Lin Z, Fang Y (2015) IL-23 and TGF-\u03b21 levels as potential predictive biomarkers in treatment of bipolar I disorder with acute manic episode. J Affect Disord 174:361\u2013366","journal-title":"J Affect Disord"},{"key":"1099_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ijnp\/pyw027","volume":"19","author":"\u015e \u015eim\u015fek","year":"2016","unstructured":"\u015eim\u015fek \u015e, Y\u00fcksel T, \u00c7im A, Kaya S (2016) Serum cytokine profiles of children with obsessive-compulsive disorders shows the evidence of autoimmunity. Int J Neuropsychopharmacol 19:1\u20136","journal-title":"Int J Neuropsychopharmacol"},{"key":"1099_CR26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4306\/pi.2016.13.5.541","volume":"13","author":"D Tokac","year":"2016","unstructured":"Tokac D, Tuzun E, Gulec H, Y\u0131lmaz V, Bireller ES, Cakmakoglu B, Kucukali CI (2016) Chemokine and chemokine receptor polymorphisms in bipolar disorder. Psychiatry Investig 13:541\u2013548","journal-title":"Psychiatry Investig"},{"key":"1099_CR27","first-page":"11","volume":"8","author":"YM Han","year":"2017","unstructured":"Han YM, Cheung WK, Wong CK, Sze SL, Cheng TW, Yeung MK, Chan AS (2017) Distinct cytokine and chemokine profiles in autism spectrum disorders. Front Immunol 8:11","journal-title":"Front Immunol"},{"key":"1099_CR28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.schres.2016.09.019","volume":"181","author":"S Hong","year":"2017","unstructured":"Hong S, Lee EE, Martin AS, Soontornniyomkij B, Soontornniyomkij V, Achim CL, Reuter C, Irwin MR, Eyler LT, Jeste DV (2017) Abnormalities in chemokine levels in schizophrenia and their clinical correlates. Schizophr Res 181:63\u201369","journal-title":"Schizophr Res"},{"key":"1099_CR29","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.neuro.24.1.677","volume":"24","author":"EJ Huang","year":"2001","unstructured":"Huang EJ, Reichardt LF (2001) Neurotrophins; roles in neuronal development and function. Annu Rev Neurosci 24:677\u2013736","journal-title":"Annu Rev Neurosci"},{"key":"1099_CR30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.biopsych.2005.01.008","volume":"57","author":"F Karege","year":"2005","unstructured":"Karege F, Bondolfi G, Gervasoni N, Schwald M, Aubry JM, Bertschy G (2005) Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biol Psychiatry 57:1068\u20131072","journal-title":"Biol Psychiatry"},{"key":"1099_CR31","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/mp.2010.98","volume":"16","author":"ML Molendijk","year":"2011","unstructured":"Molendijk ML, Bus BA, Spinhoven P, Penninx BW, Kenis G, Prickaerts J, Voshaar RC, Elzinga BM (2011) Serum levels of brain-derived neurotrophic factor in major depressive disorder: state-trait issues, clinical features and pharmacological treatment. Mol Psychiatry 16:1088\u20131095","journal-title":"Mol Psychiatry"},{"key":"1099_CR32","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jad.2009.07.009","volume":"122","author":"G Maina","year":"2010","unstructured":"Maina G, Rosso G, Zanardini R, Bogetto F, Gennarelli M, Bocchio-Chiavetto L (2010) Serum levels of brain-derived neurotrophic factor in drug naive obsessive-compulsive patients: a case-control study. J Affect Disord 122:174\u2013178","journal-title":"J Affect Disord"},{"key":"1099_CR33","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.jad.2011.04.002","volume":"133","author":"Y Wang","year":"2011","unstructured":"Wang Y, Mathews CA, Li Y, Lin Z, Xiao Z (2011) Brain-derived neurotrophic factor (BDNF) plasma levels in drug-na\u00efve OCD patients are lower than those in healthy people, but are not lower than those in drug-treated OCD patients. J Affect Disord 133:305\u2013310","journal-title":"J Affect Disord"},{"key":"1099_CR34","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.psychres.2012.03.034","volume":"199","author":"LF Fontenelle","year":"2012","unstructured":"Fontenelle LF, Barbosa IG, Luna JV, Rocha NP, Silva Miranda A, Teixeira AL (2012) Neurotrophic factors in obsessive-compulsive disorder. Psychiatry Res 199:195\u2013200","journal-title":"Psychiatry Res"},{"key":"1099_CR35","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0893-133X(98)00088-8","volume":"20","author":"M Maes","year":"1999","unstructured":"Maes M, Song C, Lin AH, Bonaccorso S, Kenis G, DeJongh R, Bosmans E, Scharp\u00e9 S (1999) Negative immuno regulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 20:370\u2013379","journal-title":"Neuropsychopharmacology"},{"key":"1099_CR36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S1461145702003164","volume":"5","author":"G Kenis","year":"2002","unstructured":"Kenis G, Maes M (2002) Effects of antidepressants on the production of cytokines. Int J Neuropsychopharmacology 5:401\u2013412","journal-title":"Int J Neuropsychopharmacology"},{"key":"1099_CR37","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/hup.1011","volume":"24","author":"BE Leonard","year":"2009","unstructured":"Leonard BE, Myint A (2009) The psychoneuroimmunology of depression. Hum Psychopharmacol 24:165\u2013175","journal-title":"Hum Psychopharmacol"},{"key":"1099_CR38","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1097\/00004583-199707000-00021","volume":"36","author":"J Kaufman","year":"1997","unstructured":"Kaufman J, Birmaher B, Brent D, Rao U, Flynn C, Moreci P, Williamson D, Ryan N (1997) Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry 36:980\u2013988","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1099_CR39","first-page":"109","volume":"11","author":"B G\u00f6kler","year":"2004","unstructured":"G\u00f6kler B, \u00dcnal F, Pehlivant\u00fcrk B, K\u00fclt\u00fcr E\u00c7, Akdemir D, Taner Y (2004) Reliability and validity of schedule for affective disorders and schizophrenia for school age children-present and lifetime version-turkish version (K-SADS-PL-T). Turk J Ch\u0131ld Adolesc Ment Health 11:109\u2013116","journal-title":"Turk J Ch\u0131ld Adolesc Ment Health"},{"key":"1099_CR40","volume-title":"Obsessions and compulsions","author":"S Rachman","year":"1980","unstructured":"Rachman S, Hodgson RJ (1980) Obsessions and compulsions. Prentice Hall, Englewood Cliffs"},{"key":"1099_CR41","unstructured":"Erol N, Sava\u015f\u0131r I (1998) Turkish version of Maudsley Obsessive Compulsive Questionnaire. In: paper presented at the meeting of the Turkish National Psychiatry Congress, p 107\u2013114"},{"key":"1099_CR42","first-page":"389","volume":"15","author":"RJ Hodgson","year":"1977","unstructured":"Hodgson RJ, Rachman S (1977) Obsessional-Compulsive complaints. Behavioral and research. Therapy 15:389\u2013395","journal-title":"Therapy"},{"key":"1099_CR43","first-page":"995","volume":"21","author":"M Kovacs","year":"1985","unstructured":"Kovacs M (1985) The Children\u2019s Depression, Inventory (CDI). Psychopharmacol Bull 21:995\u2013998","journal-title":"Psychopharmacol Bull"},{"key":"1099_CR44","first-page":"137","volume":"2","author":"B Oy","year":"1991","unstructured":"Oy B (1991) Children\u2019s depression inventory: a study of reliability and validity. Turk Psychiatry Derg 2:137\u2013140","journal-title":"Turk Psychiatry Derg"},{"key":"1099_CR45","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1097\/00004583-199910000-00011","volume":"38","author":"B Birmaher","year":"1999","unstructured":"Birmaher B, Brent DA, Chiappetta L, Bridge J, Monga S, Baugher M (1999) Psychometric properties of the Screen for Child Anxiety Related Emotional Disorders (SCARED): a replication study. J Am Acad Child Adolesc Psychiatry 38:1230\u20131236","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"1099_CR46","volume-title":"Reliability and validity of SCARED in Turkish children","author":"F Karaceylan","year":"2005","unstructured":"Karaceylan F (2005) Reliability and validity of SCARED in Turkish children. Dissertation, Kocaeli University, Kocaeli"},{"issue":"2","key":"1099_CR47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1469-7610.2006.01687.x","volume":"48","author":"H Lin","year":"2007","unstructured":"Lin H, Katsovich L, Ghebremichael M, Findley DB, Grantz H, Lombroso PJ, King RA, Zhang H, Leckman JF (2007) Psychosocial stress predicts future symptom severities in children and adolescents with Tourette syndrome and\/or obsessive-compulsive disorder. J Child Psychol Psychiatry 48(2):157\u2013166","journal-title":"J Child Psychol Psychiatry"},{"key":"1099_CR48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5498\/wjp.v2.i1.13","volume":"2","author":"Faravelli C Lo","year":"2012","unstructured":"Lo Faravelli C, Sauro C, Godini L, Lelli L, Benni L, Pietrini F, Lazzeretti L, Talamba GA, Fioravanti G, Ricca V (2012) Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry 2:13\u201325","journal-title":"World J Psychiatry"},{"key":"1099_CR49","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/PSY.0b013e31822fc277","volume":"7","author":"ER Blackmore","year":"2011","unstructured":"Blackmore ER, Moynihan JA, Rubinow DR, Pressman EK, Gilchrist M, O\u2019Connor TG (2011) Psychiatric symptoms and proinflammatory cytokines in pregnancy. Psychosom Med 7:656\u2013663","journal-title":"Psychosom Med"},{"key":"1099_CR50","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1073\/pnas.0610362104","volume":"4","author":"A Danese","year":"2007","unstructured":"Danese A, Pariante CM, Caspi A, Taylor A, Poulton R (2007) Childhood maltreatment predicts adult inflammation in a life-course study. Proc Natl Acad Sci 4:1319\u20131324","journal-title":"Proc Natl Acad Sci"},{"key":"1099_CR51","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.bbi.2012.05.012","volume":"26","author":"L Shaashua","year":"2012","unstructured":"Shaashua L, Sominsky L, Levi B, Sorski L, Reznick M, Page GG, Ben-Eliyahu S (2012) In vivo suppression of plasma IL-12 levels by acute and chronic stress paradigms: potential mediating mechanisms and sex differences. Brain Behav Immun 26:996\u20131005","journal-title":"Brain Behav Immun"},{"key":"1099_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0033069","volume":"7","author":"FS Dhabhar","year":"2012","unstructured":"Dhabhar FS, Saul AN, Holmes TH, Daugherty C, Neri E, Tillie JM, Kusewitt D, Oberyszyn TM (2012) High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma. PLoS ONE 7:1\u201314","journal-title":"PLoS ONE"},{"key":"1099_CR53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.psyneuen.2013.12.001","volume":"42","author":"L Shaashua","year":"2014","unstructured":"Shaashua L, Rosenne E, Neeman E, Sorski L, Sominsky L, Matzner P, Page GG, Ben-Eliyahu S (2014) Plasma IL-12 levels are suppressed in vivo by stress and surgery through endogenous release of glucocorticoids and prostaglandins but not catecholamines or opioids. Psychoneuroendocrinology 42:11\u201323","journal-title":"Psychoneuroendocrinology"},{"key":"1099_CR54","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S1286-4579(00)01359-9","volume":"3","author":"X Ma","year":"2001","unstructured":"Ma X (2001) TNF-alpha and IL-12: a balancing act in macrophage functioning. Microbes Infect 3:121\u2013129","journal-title":"Microbes Infect"},{"key":"1099_CR55","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00406-010-0116-z","volume":"261","author":"IG Barbosa","year":"2011","unstructured":"Barbosa IG, Huguet RB, Mendon\u00e7a VA, Sousa LP, Neves FS, Bauer ME, Teixeira AL (2011) Increased plasma levels of soluble TNF receptor I in patients with bipolar disorder. Eur Arch Psychiatry Clin Neurosci 261:139\u2013143","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"1099_CR56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jneuroim.2009.08.001","volume":"216","author":"P Scalzo","year":"2009","unstructured":"Scalzo P, Kummer A, Cardoso F, Teixeira AL (2009) Increased serum levels of soluble tumor necrosis factor-alpha receptor-1 in patients with Parkinson\u2019s disease. J Neuroimmunol 216:122\u2013125","journal-title":"J Neuroimmunol"}],"container-title":["European Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00787-017-1099-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-017-1099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00787-017-1099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T08:00:41Z","timestamp":1719734441000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00787-017-1099-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,4]]},"references-count":56,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["1099"],"URL":"https:\/\/doi.org\/10.1007\/s00787-017-1099-3","relation":{},"ISSN":["1018-8827","1435-165X"],"issn-type":[{"value":"1018-8827","type":"print"},{"value":"1435-165X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,4]]}}}